Skip to content

A multimodal cancer rehabilitation programme for women treated for gynaecological cancer

A multimodal cancer rehabilitation programme promoting sense of coherence for women treated for gynaecological cancer: A randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17629214
Enrollment
160
Registered
2023-11-02
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women treated for gynaecological cancer Cancer

Interventions

Each participant will be randomly assigned to either an intervention group or a control group in a 1:1 ratio using block randomisation. Participants in the intervention group will receive a 12-week mu
and (ii) engage the participants to reflect on their belief, assumptions, knowledge and goals. Participants in the control group will receive brief information on the follow-up schedule during baseli

Sponsors

Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women with a primary diagnosis of gynaecological cancers (uterine, ovarian or cervical cancers) 2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and /or chemotherapy) 3. Over 18 years old 4. Able to understand spoken Cantonese and to read Chinese 5. Having smartphones with iOS or Android operating systems 6. Consenting to participate

Exclusion criteria

Exclusion criteria: Those with unsuitable physical or mental health conditions, including visual impairment or preexisting psychosis, will be excluded as their ability to comprehend information and answer questionnaires would be affected.

Design outcomes

Primary

MeasureTime frame
Sense of coherence measured using the Chinese version of the Sense of Coherence 13-item Scale (CSOC-13) at baseline, completion of the intervention, and 12 weeks after completion

Secondary

MeasureTime frame
1. Cancer-specific distress measured using the Chinese version of the Impact of Events-Revised scale (CIES-R) at baseline, completion of the intervention, and 12 weeks after completion 2. Dietary and physical activity practices measured using the Chinese version of Health Promotion Lifestyle Profile II (HPLP-II) at baseline, completion of the intervention, and 12 weeks after completion 3. Health-related quality of life measured using the Chinese version of the Medical Outcomes Study (MOS) 36-item Short Form (SF-36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion 4. Health-related quality of life measured using the Hong Kong version of the five-level EuroQol-5 Dimension (EQ-5D-5L) every three months from baseline to 12-month post-intervention 5. Participants' experiences, perceptions and opinions explored by semi-structured interviews upon completion of the intervention

Countries

Hong Kong

Contacts

Public ContactKa Ming Chow
kmchow@cuhk.edu.hk+85239434431

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026